Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-01-22

FDA Approved: TETRABENAZINE — Original Application (Slate Run Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for tetrabenazine from Slate Run Pharmaceuticals, LLC, enabling the marketing of a generic tetrabenazine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)

Snippet

ORIG AP for TETRABENAZINE (TETRABENAZINE)